CD4 and atherosclerosis: ,22,23,34 Therefore, fatty acid-mediated metabolic reprogramming of CD4+ T cells may affect the initiation and progression of atherosclerosis by skewing CD4+ T cells toward a pro- or anti-inflammatory phenotype.